M
MEDU LABORATORIES
Vendor Ledger/Paramount Peptides
P

Paramount Peptides

AExcellent 40 products · 138 certificates

Products examined

ProductRating Samples Avg MinMaxLatest
Ipamorelin A 7 8.2 6.5 9.5 27 Feb 2025
PT-141 C 3 8.0 4.7 9.8 25 Apr 2025
Semaglutide C 9 6.3 4.6 8.9 14 Jan 2025
Retatrutide C 12 7.5 4.3 9.3 14 Jan 2025
Survodutide C 3 5.2 4.6 6.0 25 Apr 2025
BPC-157 D 11 6.8 3.2 9.0 14 Jan 2025
Tirzepatide D 11 6.8 3.6 8.9 14 Jan 2025
CJC-1295 E 9 4.9 2.2 6.8 14 Jan 2025
17a-Methyl-1-Testosterone A 6 7.2 4.3 9.4 23 May 2026
4-Anilinopiperidine CAS 99918-43-1 A 6 6.5 3.6 7.9 25 May 2026
Adipotide X 1 5.2 5.2 5.2 14 Jan 2025
Alprostadil X 1 6.9 6.9 6.9 6 May 2025
APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 A 6 7.1 3.7 9.6 24 May 2026
Boldenone Undecylenate (EQ) Raw A 3 7.8 6.8 8.6 24 May 2026
BPC 500mcg + TB500 500mcg Blend Oral A 6 6.5 5.5 8.3 25 May 2026
Cagrilintide 5mg + Semaglutide 5mg Blend A 6 7.1 5.0 10.0 23 May 2026
Cerebrolysin A 6 6.0 5.4 7.7 24 May 2026
CJC-1295 w/o DAC 10mg + IPA 10mg Blend A 2 6.5 6.2 6.7 24 May 2026
DHB (1-Test Cyp) Oral X 1 6.2 6.2 6.2 7 May 2025
DNP A 5 6.1 4.7 7.9 20 May 2026
GHRP-2 Acetate A 6 7.4 5.5 9.5 25 May 2026
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg A 4 6.8 6.1 8.1 17 May 2026
HGH 191AA (Somatropin) A 5 6.4 5.3 7.4 20 May 2026
Hyaluronic acid A 5 6.3 3.8 8.0 21 May 2026
IGF-1 LR3 A 6 6.5 4.4 9.1 25 May 2026
Ivermectin A 6 6.4 4.6 8.4 21 May 2026
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg A 2 5.4 4.6 6.3 21 May 2026
KPV Oral A 3 7.0 6.2 7.7 21 May 2026
N-Acetyl Epitalon Amidate A 6 5.9 3.5 8.0 25 May 2026
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend A 2 7.2 4.5 10.0 20 May 2026
Nandrolone Decanoate (Deca) Raw X 1 6.4 6.4 6.4 3 Jun 2025
NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 A 6 6.5 4.4 9.3 24 May 2026
P21 A 3 7.4 7.0 7.6 17 May 2026
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 A 6 6.9 5.4 8.4 24 May 2026
Retatrutide Raw A 3 7.1 4.1 10.0 21 May 2026
Salbutamol A 3 6.9 6.1 7.4 24 May 2026
Tesamorelin 11mg + Ipamorelin 6mg Blend A 6 7.3 4.8 9.0 24 May 2026
Test Suspension A 4 6.0 5.2 7.0 23 May 2026
Vesugen A 2 7.7 6.9 8.4 25 May 2026
Vilon A 3 6.8 6.4 7.5 21 May 2026

The certificates

DateProductScoreDeclared MeasuredDeviationPurityLaboratory
25 May 2026 BPC 500mcg + TB500 500mcg Blend Oral 6.9 100mg 108.5mg +8.5% 97.01% Lab A
25 May 2026 GHRP-2 Acetate 6.9 15mg 17.4mg +15.9% 98.34% Lab D
25 May 2026 Ivermectin 6.2 50mg 46.2mg -7.7% 99.94% Lab A
25 May 2026 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 5.4 100g 93.0g -7.0% 98.19% Lab D
24 May 2026 Adipotide 7.1 20mg 20.8mg +4.2% 99.48% Lab E
24 May 2026 Cerebrolysin 8.7 15mg 15.0mg -0.2% 98.02% Lab G
24 May 2026 HGH 191AA (Somatropin) 5.9 50mg 55.4mg +10.8% 97.50% Lab G
24 May 2026 Vilon 6.8 5mg 5.0mg +0.6% 97.83% Lab A
24 May 2026 GHRP-2 Acetate 8.6 15mg 17.0mg +13.6% 99.78% Lab D
24 May 2026 GHRP-2 Acetate 6.6 50mg 48.5mg -3.1% 98.75% Lab F
24 May 2026 17a-Methyl-1-Testosterone 8.6 20mg 20.2mg +1.1% 95.61% Lab G
24 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 7.2 30mg 35.8mg +19.2% 99.21% Lab C
24 May 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 8.8 500g 590.4g +18.1% 99.84% Lab D
24 May 2026 BPC 500mcg + TB500 500mcg Blend Oral 5.1 10mg 12.3mg +22.9% 98.02% Lab D
24 May 2026 Cerebrolysin 6.0 10mg 8.8mg -12.4% 96.46% Lab G
24 May 2026 Ivermectin 5.8 25mg 22.2mg -11.2% 99.34% Lab B
24 May 2026 Salbutamol 6.6 50mg 52.7mg +5.3% 98.67% Lab G
24 May 2026 Test Suspension 6.4 200mg/ml 207.9mg/ml +4.0% 99.52% Lab F
24 May 2026 4-Anilinopiperidine CAS 99918-43-1 4.3 5g 5.4g +8.2% 96.69% Lab G
24 May 2026 KPV Oral 6.9 100mg 96.6mg -3.4% 96.51% Lab B
24 May 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 6.9 500g 541.5g +8.3% 98.26% Lab D
24 May 2026 Test Suspension 5.3 100mg/ml 109.4mg/ml +9.4% 95.28% Lab D
24 May 2026 Test Suspension 4.5 250mg/ml 300.8mg/ml +20.3% 97.56% Lab G
23 May 2026 4-Anilinopiperidine CAS 99918-43-1 6.0 500g 568.7g +13.7% 97.83% Lab D
23 May 2026 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 7.7 100g 96.2g -3.8% 98.29% Lab B
23 May 2026 CJC-1295 w/o DAC 10mg + IPA 10mg Blend 6.6 50mg 45.4mg -9.2% 99.11% Lab E
23 May 2026 GHRP-2 Acetate 6.9 50mg 42.8mg -14.3% 96.88% Lab G
23 May 2026 Hyaluronic acid 5.3 20mg 18.4mg -8.0% 99.67% Lab B
23 May 2026 KPV Oral 4.9 50mg 50.4mg +0.9% 99.25% Lab E
23 May 2026 GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg 8.0 10mg 11.4mg +14.5% 99.79% Lab G
23 May 2026 Hyaluronic acid 5.1 15mg 15.3mg +1.7% 98.70% Lab B
23 May 2026 IGF-1 LR3 5.3 15mg 18.6mg +24.3% 96.82% Lab F
23 May 2026 N-Acetyl Epitalon Amidate 4.8 20mg 20.2mg +1.0% 99.44% Lab G
21 May 2026 HGH 191AA (Somatropin) 7.3 15mg 13.4mg -10.8% 97.16% Lab B
21 May 2026 IGF-1 LR3 5.4 5mg 5.4mg +8.1% 96.58% Lab A
21 May 2026 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 7.1 5g 5.7g +14.6% 97.02% Lab A
21 May 2026 17a-Methyl-1-Testosterone 5.8 100mg 95.3mg -4.7% 95.83% Lab A
21 May 2026 4-Anilinopiperidine CAS 99918-43-1 7.7 100g 89.0g -11.0% 95.57% Lab A
21 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 8.1 5mg 5.5mg +9.1% 98.66% Lab E
21 May 2026 IGF-1 LR3 5.8 30mg 25.9mg -13.5% 97.17% Lab A
21 May 2026 Ivermectin 7.2 20mg 18.2mg -8.9% 99.03% Lab G
21 May 2026 NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend 5.7 50mg 53.6mg +7.2% 96.57% Lab A
21 May 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 6.1 100g 125.0g +25.0% 98.78% Lab G
21 May 2026 Salbutamol 7.7 50mg 52.0mg +4.0% 98.58% Lab E
21 May 2026 Test Suspension 6.6 100mg/ml 118.6mg/ml +18.6% 98.41% Lab D
20 May 2026 4-Anilinopiperidine CAS 99918-43-1 6.7 500g 566.7g +13.3% 98.85% Lab B
20 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 5.1 10mg 12.2mg +21.6% 97.07% Lab G
20 May 2026 GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg 7.3 2mg 1.8mg -9.3% 96.59% Lab C
20 May 2026 Hyaluronic acid 6.1 10mg 11.6mg +15.7% 97.31% Lab G
20 May 2026 Tesamorelin 11mg + Ipamorelin 6mg Blend 7.0 20mg 20.7mg +3.5% 99.56% Lab F
19 May 2026 BPC 500mcg + TB500 500mcg Blend Oral 5.2 100mg 124.8mg +24.8% 96.61% Lab F
19 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 6.8 30mg 27.1mg -9.8% 95.53% Lab F
19 May 2026 Cerebrolysin 5.0 20mg 18.3mg -8.6% 96.06% Lab E
19 May 2026 DHB (1-Test Cyp) Oral 6.4 20mg 24.1mg +20.7% 98.21% Lab D
19 May 2026 Ivermectin 8.1 100mg 110.9mg +10.9% 95.91% Lab G
17 May 2026 Tirzepatide 6.5 20mg 22.1mg +10.5% 99.08% Lab E
17 May 2026 4-Anilinopiperidine CAS 99918-43-1 6.3 500g 606.1g +21.2% 98.13% Lab F
29 Jan 2026 17a-Methyl-1-Testosterone 5.6 50mg 44.5mg -11.1% 97.65% Lab C
29 Jan 2026 DNP 5.8 100mg 95.3mg -4.7% 98.18% Lab C
29 Jan 2026 HGH 191AA (Somatropin) 7.1 10mg 11.9mg +19.0% 97.70% Lab B
29 Jan 2026 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 5.2 30mg 26.6mg -11.2% 99.07% Lab D
29 Jan 2026 N-Acetyl Epitalon Amidate 8.8 50mg 50.7mg +1.4% 95.80% Lab F
29 Jan 2026 N-Acetyl Epitalon Amidate 5.5 10mg 10.1mg +1.3% 99.92% Lab F
29 Jan 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 7.5 500g 619.3g +23.9% 98.81% Lab A
29 Jan 2026 Tesamorelin 11mg + Ipamorelin 6mg Blend 8.3 50mg 49.1mg -1.8% 95.15% Lab B
26 Jan 2026 Boldenone Undecylenate (EQ) Raw 8.6 10g 8.7g -12.9% 95.95% Lab A
26 Jan 2026 Ivermectin 6.4 100mg 105.3mg +5.3% 98.14% Lab C
26 Jan 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 5.8 5g 4.6g -7.5% 99.18% Lab D
19 Jan 2026 DNP 7.2 10mg 11.9mg +18.8% 95.24% Lab E
19 Jan 2026 NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend 6.4 30mg 27.6mg -8.0% 96.67% Lab D
19 Jan 2026 Tesamorelin 11mg + Ipamorelin 6mg Blend 7.9 50mg 48.6mg -2.7% 99.94% Lab D
9 Jan 2026 HGH 191AA (Somatropin) 6.0 5mg 4.4mg -11.7% 99.75% Lab C
9 Jan 2026 Retatrutide Raw 7.7 1g 0.9g -13.2% 97.51% Lab A
7 Jan 2026 DNP 4.9 10mg 9.4mg -6.0% 95.13% Lab F
7 Jan 2026 P21 6.0 2mg 2.2mg +8.4% 95.94% Lab D
7 Jan 2026 Tesamorelin 11mg + Ipamorelin 6mg Blend 9.2 5mg 5.6mg +11.2% 96.06% Lab G
6 Jan 2026 IGF-1 LR3 6.3 20mg 22.2mg +10.9% 97.53% Lab G
6 Jan 2026 N-Acetyl Epitalon Amidate 5.4 10mg 9.5mg -4.6% 98.78% Lab F
6 Jan 2026 Retatrutide Raw 5.5 500g 496.3g -0.7% 98.06% Lab B
6 Jan 2026 Vesugen 9.1 20mg 17.1mg -14.7% 98.71% Lab A
29 Dec 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 8.2 100g 123.2g +23.2% 98.66% Lab F
29 Dec 2025 Boldenone Undecylenate (EQ) Raw 8.3 100g 91.1g -8.9% 99.40% Lab F
29 Dec 2025 CJC-1295 w/o DAC 10mg + IPA 10mg Blend 5.5 20mg 18.8mg -6.2% 97.21% Lab C
29 Dec 2025 GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg 7.1 5mg 5.2mg +3.9% 98.35% Lab A
29 Dec 2025 Hyaluronic acid 6.4 20mg 20.0mg -0.1% 97.74% Lab A
29 Dec 2025 IGF-1 LR3 5.1 2mg 1.9mg -2.5% 99.33% Lab B
29 Dec 2025 P21 5.8 2mg 1.8mg -12.4% 99.54% Lab G
29 Dec 2025 Vesugen 6.5 50mg 56.1mg +12.3% 95.41% Lab B
12 Dec 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 5.8 500g 575.8g +15.2% 95.19% Lab F
12 Dec 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 6.6 10g 12.5g +24.8% 97.10% Lab C
12 Dec 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 6.8 5mg 5.0mg -0.5% 95.41% Lab G
12 Dec 2025 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 8.2 10g 12.1g +20.6% 96.05% Lab G
12 Dec 2025 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 7.1 5g 6.0g +19.4% 95.35% Lab D
12 Dec 2025 Tesamorelin 11mg + Ipamorelin 6mg Blend 6.3 2mg 1.9mg -6.1% 98.54% Lab F
6 Dec 2025 Retatrutide 7.4 5mg 5.07mg +1.4% 99.67% Lab E
6 Dec 2025 Retatrutide 8.0 20mg 20.5mg +2.5% 99.95% Lab E
6 Dec 2025 Retatrutide 8.0 10mg 10.4mg +4.0% 99.95% Lab E
5 Dec 2025 Alprostadil 7.0 15mg 15.0mg +0.0% 98.96% Lab A
5 Dec 2025 DNP 6.4 20mg 20.6mg +2.9% 95.35% Lab A
5 Dec 2025 Nandrolone Decanoate (Deca) Raw 9.0 100g 88.6g -11.4% 99.35% Lab A
23 Nov 2025 17a-Methyl-1-Testosterone 8.2 50mg 48.1mg -3.8% 98.12% Lab D
23 Nov 2025 BPC 500mcg + TB500 500mcg Blend Oral 6.5 20mg 17.9mg -10.6% 95.33% Lab A
23 Nov 2025 DNP 5.6 10mg 9.6mg -4.2% 98.72% Lab C
23 Nov 2025 N-Acetyl Epitalon Amidate 5.5 20mg 23.2mg +15.8% 98.70% Lab D
23 Nov 2025 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 7.1 1g 0.9g -13.2% 95.56% Lab F
23 Nov 2025 Retatrutide Raw 6.8 10g 11.1g +11.2% 99.30% Lab C
17 Nov 2025 BPC 500mcg + TB500 500mcg Blend Oral 7.7 20mg 21.1mg +5.7% 99.10% Lab A
17 Nov 2025 HGH 191AA (Somatropin) 7.1 2mg 1.9mg -4.0% 96.78% Lab F
17 Nov 2025 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 7.7 100g 98.2g -1.8% 98.24% Lab E
14 Nov 2025 17a-Methyl-1-Testosterone 6.5 20mg 20.7mg +3.3% 96.01% Lab C
14 Nov 2025 Boldenone Undecylenate (EQ) Raw 9.2 100g 94.7g -5.3% 95.35% Lab E
14 Nov 2025 BPC 500mcg + TB500 500mcg Blend Oral 5.1 50mg 55.4mg +10.8% 98.83% Lab D
14 Nov 2025 Vilon 8.0 30mg 32.1mg +6.9% 95.39% Lab F
5 Nov 2025 Cerebrolysin 5.5 15mg 13.0mg -13.1% 97.71% Lab E
5 Nov 2025 Ivermectin 4.0 25mg 21.4mg -14.5% 96.92% Lab F
5 Nov 2025 Tesamorelin 11mg + Ipamorelin 6mg Blend 6.8 10mg 9.7mg -2.5% 99.42% Lab D
4 Nov 2025 17a-Methyl-1-Testosterone 9.1 20mg 20.4mg +2.2% 96.95% Lab B
4 Nov 2025 4-Anilinopiperidine CAS 99918-43-1 4.9 10g 11.4g +14.4% 96.81% Lab F
4 Nov 2025 Cerebrolysin 6.2 2mg 2.5mg +25.0% 99.91% Lab D
4 Nov 2025 GHRP-2 Acetate 9.2 15mg 14.7mg -1.7% 98.39% Lab B
4 Nov 2025 GHRP-2 Acetate 8.4 5mg 5.5mg +10.1% 98.46% Lab E
4 Nov 2025 GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg 7.5 5mg 4.3mg -14.3% 95.76% Lab B
4 Nov 2025 KPV Oral 6.0 100mg 119.6mg +19.6% 98.06% Lab D
4 Nov 2025 NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 5.9 100g 119.8g +19.8% 95.80% Lab E
4 Nov 2025 P21 8.5 20mg 18.5mg -7.4% 99.99% Lab C
17 Oct 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 6.6 10g 9.4g -5.9% 96.49% Lab B
17 Oct 2025 Hyaluronic acid 6.5 50mg 52.5mg +5.0% 95.90% Lab C
9 Oct 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 6.6 5g 6.1g +21.0% 95.58% Lab A
9 Oct 2025 Cerebrolysin 6.5 15mg 13.8mg -8.2% 95.42% Lab E
9 Oct 2025 Salbutamol 6.5 100mg 118.5mg +18.5% 96.80% Lab G
3 Oct 2025 BPC-157 8.0 5mg 4.92mg -1.6% 99.95% Lab E
3 Oct 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 5.6 50mg 49.9mg -0.3% 96.02% Lab C
3 Oct 2025 IGF-1 LR3 6.5 10mg 12.2mg +22.1% 98.13% Lab D
3 Oct 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 6.8 5mg 4.7mg -5.9% 96.15% Lab D
3 Oct 2025 N-Acetyl Epitalon Amidate 6.6 5mg 5.2mg +5.0% 95.85% Lab D
3 Oct 2025 Vilon 5.7 10mg 9.1mg -9.4% 96.93% Lab F
16 Jul 2025 Tirzepatide 6.5 5mg 5.47mg +9.4% 99.83% Lab E
10 Jul 2025 BPC-157 5.6 5mg 5.17mg +3.4% 98.57% Lab A